Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07164222

Triglycerides Glucose Index and Ratio on Diabetic Type 2

Triglycerides glucose index and ratio on diabetic type 2

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

About this study

Triglycerides glucose index and ratio on patients with type 2 diabetes mellitus and microvacular complications

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • above 18years under 65years

Exclusion criteria

Type 1 diabetic Under 18years Severe complications Icu patients Blind and handicapped patients

-

Treatment and study plan

Glycated haemoglobin and triglycerides level

Diagnostic Test

Follow up with triglycerides and glucose index and ratio on diabetic type 2

Primary outcomes

  1. Follow up with routine investigations for diabetic cases

    Time frame: 2years

    Microvacular complications with diabetic

Study contacts

Contact information is provided by the study sponsor or research team.

DEAAELDIN MOHAMED Mohamed Consultant DEAAELDIN sedek, Fellowship internal medecine d

CONTACT

[email protected]

00201093439393 ext. 0020882102677

Sponsors and collaborators

Lead sponsor

Assiut University

Other

Registry information

Official study title

Triglycerides Glucose Index on Diabetic Patients Type 2

Acronym: Diabetes 2

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Sep 10, 2025
Registry last updated
Sep 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.